학술논문

Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D plus /-T) in head and neck squamous cell carcinoma (HNSCC)
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2023, 41 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755